As we know the multi-stakeholder world is increasingly complex, with shifting dynamics and stakeholder groups engaging in different ways, through different channels, at
different times and by different customer-facing functions. It’s
essential that a multi-stakeholder approach is taken or we run
the risk of falling behind.

In this whitepaper we explore the new integrated multi-stakeholder
approach and reflect on the impact it’s having on the industry as
a whole.

Find out more by downloading your free copy today >>>

With expert contributions from:

  • Hans Gilhuyus, Global Multi Channel Capabilities Director, GSK
  • Jane Griffiths, Global Head, Actelion
  • Markus Kosch, Vice President, Oncology Portfolio, Europe,
    Japan & Developed Asia
    , Pfizer Oncology
  • Sebastian Guth, Executive Vice President and Chief
    Marketing Officer
    , Bayer Pharmaceuticals
  • Barrett Madrigal, Senior Director Eli Lilly Japan KK. Operation
    Officer,
    Member of Global Bio-Medicines Lead Team
  • Bob Oliver, Chief Executive Officer, VClinBio
  • Kabir Nath, CEO, Otsuka Pharmaceuticals US

Discover how the integrated multi-channel approach will change pharma forever, download your copy today >>>

Kind regards,

Balancing payers, patients and physicians: An integrated, multi-stakeholder approach

eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909.

Terms and conditions | Privacy Policy

Fill in your details below and we’ll send you your content straight to your inbox